A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis FJH Brims, TM Meniawy, I Duffus, D de Fonseka, A Segal, J Creaney, ... Journal of Thoracic Oncology 11 (4), 573-582, 2016 | 163 | 2016 |
Empyema thoracis: new insights into an old disease FJH Brims, SM Lansley, GW Waterer, YCG Lee European Respiratory Review 19 (117), 220-228, 2010 | 144 | 2010 |
Ambulatory treatment in the management of pneumothorax: a systematic review of the literature FJH Brims, NA Maskell Thorax 68 (7), 664-669, 2013 | 143 | 2013 |
Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients RS Finn, FJH Brims, A Gandhi, N Olsen, AW Musk, NA Maskell, YCG Lee Chest 142 (5), 1267-1273, 2012 | 128 | 2012 |
Advance care planning uptake among patients with severe lung disease: a randomised patient preference trial of a nurse-led, facilitated advance care planning intervention C Sinclair, KA Auret, SF Evans, F Williamson, S Dormer, A Wilkinson, ... BMJ open 7 (2), e013415, 2017 | 105 | 2017 |
Coal workers’ pneumoconiosis: an Australian perspective GR Zosky, RF Hoy, EJ Silverstone, FJ Brims, S Miles, AR Johnson, ... The Medical Journal of Australia 204 (11), 414-418, 2016 | 105 | 2016 |
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study MC Tammemägi, M Ruparel, A Tremblay, R Myers, J Mayo, J Yee, ... The Lancet Oncology 23 (1), 138-148, 2022 | 100 | 2022 |
Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids FJH Brims, AJ Chauhan, B Higgins, JK Shute Thorax 64 (12), 1037-1043, 2009 | 93 | 2009 |
Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool M Weber, S Yap, D Goldsbury, D Manners, M Tammemagi, H Marshall, ... International journal of cancer 141 (2), 242-253, 2017 | 88 | 2017 |
Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma J Creaney, NJ Olsen, F Brims, IM Dick, AW Musk, NH de Klerk, SJ Skates, ... Cancer epidemiology, biomarkers & prevention 19 (9), 2238-2246, 2010 | 85 | 2010 |
Protocol and rationale for the international lung screening trial KP Lim, H Marshall, M Tammemägi, F Brims, A McWilliams, E Stone, ... Annals of the American Thoracic Society 17 (4), 503-512, 2020 | 75 | 2020 |
Routine laboratory tests can predict in-hospital mortality in acute exacerbations of COPD AC Asiimwe, FJH Brims, NP Andrews, DR Prytherch, BR Higgins, ... Lung 189, 225-232, 2011 | 70 | 2011 |
Outcomes and complications following medical thoracoscopy FJH Brims, M Arif, AJ Chauhan The clinical respiratory journal 6 (3), 144-149, 2012 | 57 | 2012 |
Respiratory chest pain: diagnosis and treatment FJH Brims, HE Davies, YCG Lee Medical Clinics 94 (2), 217-232, 2010 | 56 | 2010 |
Pneumothorax—time for new guidelines? R Hallifax, JP Janssen Seminars in respiratory and critical care medicine 40 (03), 314-322, 2019 | 43 | 2019 |
Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial F Brims, S Gunatilake, I Lawrie, L Marshall, C Fogg, C Qi, L Creech, ... Thorax 74 (4), 354-361, 2019 | 42 | 2019 |
Asbestos–a legacy and a persistent problem FJH Brims Journal of the Royal Naval Medical Service 95 (1), 2009 | 40 | 2009 |
Occupational lung diseases in Australia RF Hoy, F Brims Medical Journal of Australia 207 (10), 443-448, 2017 | 39 | 2017 |
Bacteriology and clinical outcomes of patients with culture‐positive pleural infection in Western Australia: a 6‐year analysis F Brims, N Popowicz, A Rosenstengel, J Hart, A Yogendran, CA Read, ... Respirology 24 (2), 171-178, 2019 | 38 | 2019 |
Epidemiology and clinical aspects of malignant pleural mesothelioma F Brims Cancers 13 (16), 4194, 2021 | 37 | 2021 |